<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000736792"><TermName>iodine I 123 metaiodobenzylguanidine</TermName><TermPronunciation>(I-oh-dine … meh-tuh-I-oh-doh-BEN-zul-GWAH-nih-deen)</TermPronunciation><TermDefinition><DefinitionText>A drug containing a form of radioactive iodine called I 123 that is used to detect certain types of tumors, including pheochromocytomas and neuroblastomas. Radiation from the I 123 may help show where cancer cells are in the body. Iodine I 123 metaiodobenzylguanidine is a type of radioimaging agent and a type of radioconjugate. Also called 123I-MIBG, AdreView,  and iobenguane I 123.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000742991" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;iodine I 123 metaiodobenzylguanidine&quot;" language="en" id="_4"/><MediaLink ref="CDR0000742990" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;yodo  I 123 metayodobenzilguanidina&quot;" language="es" id="_3"/><SpanishTermName>yodo I 123 metayodobenzilguanidina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que contiene una forma de yodo radiactivo que se llama I 123. Se usa para detectar ciertos tipos de tumores, como los feocromocitomas y los neuroblastomas. La radiación del I 123 puede ayudar a identificar los lugares del cuerpo donde hay células cancerosas. El yodo I 123 metayodobenzilguanidina es un tipo de sustancia para radioimaginología y un tipo de radioconjugado. También se llama 123I-MIBG, AdreView,  y iobenguano I 123.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2012-11-01</DateFirstPublished><DateLastModified>2012-11-01</DateLastModified></GlossaryTerm>
